Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus

Aquatic Toxicology

Volumn 100, Issue 1, 2010, Pages 128-137

  Mennigen, Jan A ^a   Sassine, J ^a   Trudeau, Vance L ^a   Moon, Thomas W ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Brain; Energy metabolism; Feeding; Fluoxetine; Liver; Neuropeptides; Toxicology

Indexed keywords

ANOREXIGENIC AGENT; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLYCOLYTIC ENZYME; HEXOKINASE; LIVER ENZYME; NEUROPEPTIDE; NEUROPEPTIDE Y; GLUCOKINASE; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR;

BIOACCUMULATION; BODY MASS; BRAIN; ENZYME ACTIVITY; FISH; GENE EXPRESSION; NUTRITIONAL STATUS; POLLUTION EFFECT; TOXICOLOGY; WASTEWATER;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY MASS; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENZYME ACTIVITY; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GOLDFISH; HYPOTHALAMUS; LIVER; MALE; MUSCLE TISSUE; NEUROENDOCRINE SYSTEM; NEUROTOXICITY; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; EATING; ENZYMOLOGY; GENETICS; METABOLISM; WATER POLLUTANT; WEIGHT GAIN;

ANIMALIA; CARASSIUS AURATUS;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; FLUOXETINE; FRUCTOSE-BISPHOSPHATASE; GLUCOKINASE; GLUCOSE; GOLDFISH; HEXOKINASE; LIVER; NEUROPEPTIDE Y; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; WATER POLLUTANTS, CHEMICAL; WEIGHT GAIN;

EID: 77957567376     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2010.07.022     Document Type: Article

References (63)

1. Baker R.A., Herkenham M., Brady L.S. Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats. J. Neuroendocrinol. 1996, 8:337-343.
2. Briscoe V.J., Ertl A.C., Tate D.B., Dawling S., Davis S.N. Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. Diabetes 2008, 57:2453-2460.
3. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon D.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142:169-183.
4. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
5. Brooks B.W., Huggett D.B., Boxall A.B. Pharmaceuticals and personal care products: research needs for the next decade. Environ. Toxicol. Chem. 2009, 28:2469-2472.
6. Carvalho F., Barros D., Silva J., Rezende E., Soares M., Fregoneze J., De Castro e Silva E. Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors. Neuropeptides 2004, 38:98-105.
7. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1163:112-118.
8. Cui Z., Wang Y. Temporal changes in body mass, body composition and metabolism of gibel carp Carassius auratus gibelio during food deprivation. J. Appl. Ichthyol. 2007, 23:215-220.
9. Deeg M.A., Lipkin E.W. Hypoglycemia associated with the use of fluoxetine. West. J. Med. 1996, 164:262-263.
10. dePedro N., Pinillos M.L., Valenciano A.I., Alonso-Bedate M., Delgado M.J. Inhibitory effect of serotonin on feeding behavior in goldfish: involvement of CRF. Peptides 1998, 19:505-511.
11. de Vane C.L. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell. Mol. Neurobiol. 2000, 19:443-466.
12. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
13. Enes P., Panserat S., Kaushik S., Oliva-Teles A. Nutrition regulation of hepatic glucose metabolism in fish. Fish Physiol. Biochem. 2009, 35:519-539.
14. Ferenczi S., Zelei E., Pintér B., Szo{double acute}ke Z., Kovács K.J. Differential regulation of hypothalamic neuropeptide Y hnRNA and mRNA during psychological stress and insulin-induced hypoglycemia. Mol. Cell. Endocrinol. 2010, 10.1016/j.mce.2010.02.036.
15. Fox B.K., Breves J.P., Hirano T., Grau E.G. Effects of short- and long-term fasting on plasma and stomach ghrelin, and the growth hormone/insulin-like growth factor I axis in the tilapia, Oreochromis mossambicus. Dom. Anim. Endocrinol. 2009, 37:1-11.
16. Gaworecki K.M., Klaine S.J. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat. Toxicol. 2008, 88:207-213.
17. Gould G.G., Brooks B.W., Frazer A. [(3)H] Citalopram binding to serotonin transporter sites in minnow brains. Basic Clin. Pharmacol. Toxicol. 2007, 101:203-210.
18. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., Blundell J.E. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007, 67:27-55.
19. Hartke, K., Mutschler, E., 1993. Deutsches Arzneibuch DAB 10-Kommentar, 10th ed., vols. II and III, 3rd supplement. Deutscher Apotheker-Verlag, Stuttgart.
20. Hiemke C., Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 2000, 85:11-28.
21. Hutchinson T.H., Mashid Y., Jonsson R., Bjorklund C., Kenne K. Proteomic analysis of phospholipidosis in citalopram treated U937 cells-support for cholesterol biosynthesis hypothesis. J. Clin. Psychol. 2006, 67:1974-1982.
22. IMS Health, 2006. Commonly Requested Therapeutic Class and Product Information. IMS Health, Inc. (http://www.imshealth.com/ims/portalfromt/articleC/0,2777,6599_1873177056778,00.html.
23. Janssens P.A., Waterman J. Hormonal regulation of gluconeogenesis and glycogenolysis in carp (Cyprinus carpio) liver pieces cultured in vitro. Comp. Biochem. Physiol. 1988, 91A:451-455.
24. Jørgensen H., Knigge U., Kjaer A., Møller M., Warberg J. Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. J. Neuroendocrinol. 2002, 14:788-795.
25. Kah O., Chambolle P. Serotonin in the brain of the goldfish. Carassius auratus. An immunocytochemical study. Cell Tissue Res. 1983, 234:319-333.
26. Kavaraj A., Bhunia F., Saha N.C. Toxicity of methanol to fish, crustacean, oligochaete worm, and aquatic ecosystem. Int. J. Toxicol. 2004, 23:55-63.
27. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Tech. 2002, 36:1202-1211.
28. Kreke N., Dietrich D.R. Physiological endpoints for potential SSRI interactions in fish. Crit. Rev. Toxicol. 2008, 38:215-247.
29. Kwon J.W., Armbrust K.L. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ. Toxicol. Chem. 2006, 25:2561-2568.
30. Lam D.D., Heisler L.K. Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev. Mol. Med. 2007, 9:1-24.
31. Marchant T.A., Peter R.E. Seasonal variation in body growth rates and circulating levels of growth hormone in goldfish, Carassius auratus. J. Exp. Zool. 1986, 237:231-239.
32. Mennigen J., Crump K., Xiong H., Zhao E., Popesku P., Anisman H., Xia X., Trudeau V.L. The effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol. Genomics 2008, 35:273-282.
33. Mennigen J.A., Harris E.A., Chang J.P., Moon T.W., Trudeau V.L. Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain. Regul. Pept. 2009, 155:99-104.
34. Mennigen, J.A., Lado, W.E., Zamora, J.M., Chang, J.P., Moon, T.W., Trudeau, V.L. Fluoxetine disrupts the male reproductive axis in sexually mature male goldfish, Carassius auratus, submitted for publication.
35. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29:79-89.
36. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 2003, 22:2881-2889.
37. Moon T.W., Johnston I.A. Starvation and the activities of glycolytic and gluconeogenic enzymes in skeletal muscles and liver of the plaice, Pleuronectes platessa. J. Comp. Physiol. 1980, 136:31-38.
38. Moon T.W., Foster G.D., Plisetskaya E.M. Changes in peptide-hormones and liver-enzymes in the rainbow-trout deprived of food for 6 weeks. Can. J. Zool. 1989, 67:2189-2193.
39. Moon T.W., Foster G.D. Tissue carbohydrate metabolism, gluconeogenesis and hormonal and environmental influences. Biochemistry and Molecular Biology of Fishes 1995, vol. 4:65-100. Elsevier, Amsterdam.
40. Nanaware, Peter R.E. Influence of diet composition on food-intake and neuropeptide Y expression (NPY) gene expression in goldfish brain. Regul. Pept. 2002, 103:75-83.
41. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., Tatarazako N. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 2008, 70:865-873.
42. Navarro I., Gutiérrez J. Fasting and starvation. Biochemistry and Molecular Biology of Fishes 1995, vol. 4:393-434. Elsevier, Amsterdam.
43. Nishiyama M., Makino S., Iwasaki Y., Tanaka Y., Nazarloo H.P., Kaneda T., Asaba K., Hashimoto K. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation. Brain Res. 2008, 1228:107-112.
44. Oakes K.D., Coors A., Escher B., Fenner K., Garric J., Gus t.M., Knacker T., Kuster A., Kussatz C., Metcalfe C.D., Monteiro S., Moon T., Mennigen J.A., Parrott J., Pery A.R., Ramil M., Tarazona J.V., Sanchez-Arguello P., Ternes T.A., Trudeau V.L., Boucard T., Van der Kraak G.J., Servos M. An environmental risk assessment for the serotonin reuptake inhibitor fluoxetine-a case study utilizing the European risk assessment framework. Integr. Environ. Asess. Manag. 2010, 6:1-16.
45. Panserat S., Médale F., Blin C., Brèque J., Vachot C., Plagnes-Juan E., Gomes E., Krishnamoorthy R., Kaushik S. Hepatic glucokinase is induced by dietary carbohydrates in rainbow trout, gilthead seabream, and common carp. Am. J. Physiol. Reg. Integr. Comp. Physiol. 2000, 278:1164-1170.
46. Panserat S., Plagnes-Juan E., Kaushik S. Gluconeogenic enzyme gene expression is decreased by dietary carbohydrates in common carp (Cyprinus carpio) and gilthead seabream (Sparus aurata). Biochim. Biophys. Acta 2002, 1579:35-42.
47. Paterson G., Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130.
48. Pelletier D., Dutil J.-D., Blier P., Guderley H. Relation between growth rate and metabolic organization of white muscle, liver and digestive tract in Cod, Gadus morhua. J. Comp. Physiol. 1994, 164B:179-190.
49. Perry S.F., Walsh P.J., Mommsen T.P., Moon T.W. Metabolic consequences of hypercapnia in the rainbow trout, Salmo gairdneri: β-adrenergic effects. Gen. Comp. Endocrinol. 1988, 69:439-447.
50. Polakof S., Skiba-Cassy S., Choubert G., Panserat S. Insulin-induced hypoglycaemia is co-ordinately regulated by liver and muscle during acute and chronic insulin stimulation in rainbow trout (Oncorhynchus mykiss). J. Exp. Biol. 2010, 213:1443-1452.
51. Polakof S., Miguez J.M., Moon T.W., Soengas J.L. Evidence for the presence of a glucosensor in hypothalamus, hindbrain, and Brockmann bodies of rainbow trout. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:1657-1666.
52. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products (PPCPs) in fish: results of a national pilot study in the U.S. Environ. Toxicol. Chem. 2009, 10.1897/08-561.1.
53. Sheridan M.A., Mommsen T.P. Effects of nutritional state on in vivo lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch. Gen. Comp. Endocrinol. 1991, 81:473-483.
54. Shikata T., Iwanaga S., Shimeno S. Effects of dietary glucose, fructose, and galactose on hepatopancreatic enzyme activities and body composition in carp. Fish Sci. 1994, 60:613-617.
55. Smith E.M., Chu S., Paterson G.M., Metcalfe C.D., Wilson J.Y. Cross-species comparison of FLX metabolism with fish liver microsomes. Chemosphere 2009, 79:26-32.
56. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
57. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
58. Thase M.E., Corya S.A., Osuntokun O., Case M., Henley D.B., Sanger T.M., Watson S.B., Dube S. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. J. Clin. Psychol. 2007, 68:224-236.
59. Troll W., Cannan R.K. A modified photometric ninhydrin method for the analysis of amino and imino acids. J. Biol. Chem. 1953, 200:803-811.
60. Vasskog T., Anderssen T., Pedersen-Bjergaard W., Kallenborn R., Jensen E. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J. Chromatogr. A 2008, 1185:194-205.
61. Volkoff H., Canosa L.F., Unniappan S., Cerdá-Reverter J.M., Bernier N.J., Kelly S.P., Peter R.E. Neuropeptides and the control of food intake in fish. Gen. Comp. Endocrinol. 2005, 142:3-19.
62. Watts A.G., Donovan C.M. Sweet talk in the brain: glucosensing neural network, hypoglycemic counterregulation. Front. Neuroendocrinol. 2009, 31:32-43.
63. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 1995, 57:411-441.